---
title: "India Glycols Ltd (INDIAGLYCO) — Share Price, Financials & Analysis"
symbol: "INDIAGLYCO"
company: "India Glycols Ltd"
canonical: "https://tapetide.com/stocks/INDIAGLYCO"
isin: "INE560A01023"
nse_symbol: "INDIAGLYCO"
bse_code: "500201"
sector: "Consumer Goods"
industry: "Breweries & Distilleries"
market_cap_cr: 2010.8
generated_at: "2026-09-13T19:59:58.224Z"
---

# India Glycols Ltd (INDIAGLYCO)

Canonical page: https://tapetide.com/stocks/INDIAGLYCO

## Company

- **NSE Symbol:** INDIAGLYCO
- **BSE Code:** 500201
- **ISIN:** INE560A01023
- **Sector:** Consumer Goods
- **Industry:** Breweries & Distilleries
- **Macro Sector:** Fast Moving Consumer Goods
- **Stock Type:** EQUITY
- **Listed Since:** 2005-07-01
- **CEO:** Mr. Uma Shankar Bhartia
- **Employees:** 1357
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** indiaglycols.com

## About

Established in 1988, India Glycols Ltd. is engaged in the manufacturing of green technology-based bulk, specialty & performance chemicals, and natural gums, spirits, industrial gases, sugar, and nutraceuticals. [1][2]

## Latest Price

- **Price:** ₹294.9
- **Change:** -15.5 (-4.99%)
- **Open:** ₹310
- **Day High:** ₹310
- **Day Low:** ₹294.9
- **Previous Close:** ₹310.4
- **Volume:** 164145
- **As Of:** 2026-09-11T10:28:04+00:00

## Key Fundamentals

Observed at 2026-09-11T04:53:37.566377Z.

- **Market Cap:** ₹2010.8 Cr
- **Classification:** Microcap
- **P/E (reported):** 6.6
- **P/E (TTM):** 6.14
- **EPS (TTM):** ₹48.02
- **Book Value:** ₹437.55
- **Price to Book:** 0.71
- **Dividend Yield:** 2.42%
- **ROE:** 9.98%
- **ROCE:** 12.07%
- **Debt to Equity:** 0.58
- **Revenue (yearly):** ₹4216.3 Cr
- **Net Income:** ₹292.8 Cr
- **EBITDA:** ₹654.2 Cr
- **52-Week High:** ₹1222
- **52-Week Low:** ₹160.37
- **RSI (14):** 80.58

## Tapetide Score

- **Score:** 52 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Falling
- **Percentile:** 56.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 31.39 | 9% |
| growth | 61.06 | 9% |
| momentum | 2.02 | 12% |
| ownership | 53.4 | 24% |
| quality | 55.73 | 22% |
| valuation | 71 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.67 times its book value

### Weaknesses

- Company has a low return on equity of 10.4% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 112.41% | 75.4% | 562.84% |
| ebitda margin growth | 5.77% | 11.74% | 20.31% | 62% |
| net income growth | 11.39% | 26.81% | 39% | 14% |
| revenue growth | 16.31% | 11.46% | 17% | 13% |
| roce | 6.62% | 1.86% | 13.76% | 11.72% |
| roe | 11.45% | -2.54% | 9.55% | -46.34% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 775 | 904 | 926 | 969 | 961 | 975 | 863 | 1040 | 1092 | 1102 | 976 | 1130 |
| Expenses | 679 | 802 | 822 | 843 | 845 | 852 | 717 | 891 | 935 | 927 | 810 | 961 |
| Operating Profit | 96 | 102 | 105 | 126 | 116 | 124 | 146 | 150 | 158 | 175 | 166 | 170 |
| OPM % | 12 | 11 | 11 | 13 | 12 | 13 | 17 | 14 | 14 | 16 | 17 | 15 |
| Other Income | 12 | 9 | 10 | 14 | 15 | 19 | 13 | 20 | 14 | 3 | 14 | 21 |
| Interest | 29 | 31 | 33 | 36 | 40 | 44 | 45 | 45 | 49 | 47 | 26 | 25 |
| Depreciation | 28 | 26 | 26 | 28 | 28 | 27 | 33 | 34 | 38 | 41 | 41 | 42 |
| Profit before tax | 50 | 54 | 56 | 76 | 63 | 71 | 82 | 91 | 84 | 91 | 112 | 123 |
| Tax % | 24 | 23 | 24 | 20 | 22 | 20 | 22 | 19 | 22 | 25 | 23 | 21 |
| Net Profit | 38 | 42 | 42 | 60 | 50 | 57 | 64 | 73 | 65 | 68 | 87 | 97 |
| EPS in Rs | 6.13 | 6.71 | 6.81 | 9.74 | 8.02 | 9.16 | 10.33 | 11.81 | 10.51 | 10.09 | 12.97 | 14.45 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3034 | 3357 | 2735 | 2317 | 2868 | 2651 | 3294 | 3768 | 4211 | 4301 |
| Expenses | 2712 | 2941 | 2433 | 2026 | 2599 | 2346 | 2879 | 3257 | 3562 | 3632 |
| Operating Profit | 322 | 416 | 303 | 291 | 269 | 305 | 415 | 511 | 649 | 669 |
| OPM % | 11 | 12 | 11 | 13 | 9 | 12 | 13 | 14 | 15 | 16 |
| Other Income | 23 | 17 | 24 | 15 | 260 | 54 | 30 | 61 | 50 | 51 |
| Interest | 125 | 143 | 97 | 83 | 70 | 100 | 121 | 164 | 167 | 148 |
| Depreciation | 73 | 76 | 78 | 80 | 80 | 94 | 101 | 115 | 155 | 163 |
| Profit before tax | 147 | 213 | 153 | 143 | 379 | 165 | 223 | 292 | 377 | 410 |
| Tax % | 34 | 38 | 25 | 8 | 10 | 15 | 23 | 21 | 22 | — |
| Net Profit | 97 | 133 | 115 | 132 | 340 | 141 | 173 | 231 | 293 | 316 |
| EPS in Rs | 15.57 | 21.39 | 18.49 | 21.23 | 54.81 | 20.17 | 27.9 | 37.25 | 43.7 | 48.02 |
| Dividend Payout % | 13 | 14 | 16 | 14 | 7 | 19 | 14 | 13 | 17 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 34 |
| Reserves | 721 | 814 | 932 | 1003 | 1138 | 1761 | 1870 | 2020 | 2225 | 2899 |
| Borrowings | 1095 | 834 | 1000 | 999 | 1137 | 1047 | 1112 | 1348 | 1892 | 1691 |
| Other Liabilities | 1645 | 1742 | 1821 | 2053 | 1814 | 1792 | 1845 | 2218 | 2029 | 1900 |
| Total Liabilities | 3492 | 3421 | 3784 | 4086 | 4119 | 4631 | 4858 | 5617 | 6176 | 6523 |
| Fixed Assets | 2111 | 2156 | 2173 | 2228 | 2193 | 2318 | 2717 | 3205 | 3829 | 4554 |
| CWIP | 91 | 89 | 137 | 172 | 126 | 243 | 125 | 84 | 98 | 37 |
| Investments | 25 | 24 | 21 | 26 | 27 | 336 | 318 | 335 | 381 | 389 |
| Other Assets | 1265 | 1152 | 1453 | 1660 | 1774 | 1734 | 1698 | 1993 | 1867 | 1543 |
| Total Assets | 3492 | 3421 | 3784 | 4086 | 4119 | 4631 | 4858 | 5617 | 6176 | 6523 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 302 | 502 | 147 | 343 | 137 | 116 | 326 | 439 | 362 | 769 |
| Cash from Investing Activity | -40 | -103 | -128 | -151 | -148 | 76 | -330 | -503 | -736 | -767 |
| Cash from Financing Activity | -263 | -399 | 3 | -216 | 11 | -189 | -1 | 90 | 354 | 23 |
| Net Cash Flow | -1 | 0 | 22 | -23 | 0 | 4 | -5 | 25 | -20 | 25 |
| Free Cash Flow | 260 | 373 | 9 | 193 | -11 | -264 | -109 | -103 | -391 | -47 |
| CFO/OP | 127 | 156 | 37 | 127 | 53 | 51 | 123 | 108 | 75 | 122 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 57 | 40 | 35 | 76 | 57 | 51 | 59 | 43 | 35 | 30 |
| Inventory Days | 129 | 87 | 124 | 146 | 166 | 148 | 209 | 224 | 209 | 139 |
| Days Payable | 144 | 152 | 143 | 155 | 158 | 137 | 209 | 222 | 175 | 123 |
| Cash Conversion Cycle | 42 | -25 | 17 | 67 | 65 | 62 | 60 | 44 | 70 | 47 |
| Working Capital Days | -117 | -78 | -50 | -64 | -79 | -31 | -46 | -63 | -56 | -49 |
| ROCE % | 9 | 15 | 20 | 14 | 10 | 9 | 8 | 11 | 12 | 12 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 61.01% | 61.01% | 61.01% | 61.01% | 61.01% | 61.01% | 61.01% | 61.01% | 61.01% | 59.63% | 59.63% | 59.63% |
| FIIs | 1.29% | 1.57% | 1.8% | 1.75% | 2.9% | 2.44% | 2.25% | 3.44% | 2.62% | 2.42% | 2.27% | 2.24% |
| DIIs | 0.08% | 0.05% | 0.08% | 0.09% | 1.94% | 2% | 0.91% | 1.39% | 1.33% | 5.23% | 5.2% | 5.22% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 30.09% | 27.72% | 27.8% | 27.34% | 26.79% | 27.82% | 28.68% | 26.8% | 27.97% | 26.27% | 26.37% | 26.15% |
| Others | 7.53% | 9.64% | 9.31% | 9.8% | 7.36% | 6.73% | 7.15% | 7.37% | 7.06% | 6.45% | 6.54% | 6.76% |
| No. of Shareholders | 47476 | 47259 | 59579 | 57768 | 54751 | 62408 | 59736 | 55149 | 54863 | 54301 | 52848 | 52968 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 2 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 447.06 | Sell |
| EMA (10) | 459.33 | Sell |
| SMA (20) | 798.46 | Sell |
| EMA (20) | 666.03 | Sell |
| SMA (50) | 990.35 | Sell |
| EMA (50) | 878.71 | Sell |
| SMA (100) | 997.88 | Sell |
| EMA (100) | 945.68 | Sell |
| SMA (200) | 974.94 | Sell |
| EMA (200) | 947.1 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 18.45 | Buy |
| MACD (12,26,9) | -229.15 | Sell |
| Stochastic (14,3,3) | 8.5 | Buy |
| ADX (14) | 46.75 | Buy |
| Williams %R (14) | -92.23 | Buy |
| ATR (14) | 70.39 | High Volatility |
| ROC (12) | -75.23 | Sell |
| Stoch RSI (14) | 12.2 | Buy |
| UO (7,14,28) | 53.42 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Material Update In Connection With IGL Spirits Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f86586fa-4238-4e2d-9cab-0d885b9a3d5b.pdf) |
| 2026-09-08 | [Material Update In Connection With Ennature Bio Pharma Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a9f7d8f-4f12-46b8-abec-20b35accda00.pdf) |
| 2026-09-07 | [Material Update In Connection With IGL Spirits Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November 2025 ("Observation Letters") Issued By The National Stock Exch](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04a4fe2a-2b3e-4042-a4ae-acd6334e0f6b.pdf) |
| 2026-09-07 | [Material Update In Connection With Ennature Bio Pharma Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November 2025 ("Observation Letters") Issued By The National S](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c47ecfe-f45d-4385-8fed-d802d6e474bf.pdf) |
| 2026-09-07 | [Intimation Of Schedule Of Analyst / Institutional Investor Meeting.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0276962-3f6d-4dbb-b0c0-f11b7027d13b.pdf) |
| 2026-09-01 | [Effectiveness Of The Scheme Of Arrangement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf225461-c17d-4c19-9653-fd3eb0bc81f1.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2906e2b6-82ae-4cd2-aa95-59563efb0c17.pdf) |
| 2026-08-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff30f261-02c9-4ff3-976e-c3c9befc3962.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84dd7ea7-6a69-4b8c-a1f4-058991eb2aed.pdf) |
| 2026-08-21 | [Fixation Of Effective Date And Record Date For Scheme Of Arrangement.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd08c9b8-4f1e-4c2b-8757-8dc34c0ef382.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e7d4037-3270-42fc-99fb-5ce8f7e1f498.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19b06026-0dde-4a60-ab18-9f2c27ed57fe.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1b68120-d313-4e5a-812e-0bb5c6578733.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b310956-452e-40d2-afcb-4a687bbad474.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8dfb15f-33b5-4366-aadf-7daffd6110d7.pdf) |
| 2026-05-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f522a026-5bc4-4d6e-92ca-ffe799e869eb.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c68849f3-0d26-4447-8688-56a7a3054943.pdf) |
| 2025-11-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be004a65-e6a0-4ee6-b12d-7fc562bf27d2.pdf) |
| 2025-08-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e987ca06-bd22-401e-919e-76f80acb1390.pdf) |
| 2025-08-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ea83ee6-e519-4638-9849-2bbec21176ad.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35d29fa8-a796-48f0-946c-1115f6beb401.pdf) |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee0fd2a1-60d1-4359-bc99-952a6b3e22b8.pdf) |
| 2026-02-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=203f7ec9-7aed-4447-a8fd-baa9312eabd6.pdf) |
| 2025-11-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c9d5844-41a1-4f6e-9b31-893a125e6567.pdf) |
| 2025-08-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b78212a8-328b-43ee-9c60-7666fbd4cfda.pdf) |
| 2025-05-26 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d532715b-c088-4be2-b619-e7a41528d1e7.pdf) |
| 2025-02-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1385769f-cd04-4add-bcad-ce6e44567146.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7af74fac-28a7-4606-9be7-11c176ebaba8.pdf) |
| 2024-08-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ab5c2dd-5699-4ed5-8c94-5842dd2bb5cb.pdf) |
| 2024-06-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47d07394-61eb-4ec4-8e04-35c30855d685.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 May - India Glycols will hold Q4 and FY26 earnings conference call on 18 May 2026 at 16:00 IST. | [Intimation Of Q4 & Full Year FY26 Earnings Conference Call 7 May - India Glycols will hold Q4 and FY26 earnings conference call on 18 May 2026 at 16:00 IST.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0c51ede6-5462-4db0-9b97-81451ae142ee.pdf) |
| 7 May - Earnings Conference Call for Q4 & Full Year FY26 will be held on Monday, 18th May, 2026 at 16.00 Hrs. (IST), as per the enclosed … | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 May - Earnings Conference Call for Q4 & Full Year FY26 will be held on Monday, 18th May, 2026 at 16.00 Hrs. (IST), as per the enclosed …](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8f7a947b-f502-4f88-8cc2-e877ca11f91a.pdf) |
| 7 May - Board meets 14 May 2026 to approve audited FY26 standalone and consolidated results; trading window closes till 16 May. | [Board Meeting Intimation for Consider And Approve The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Financial Year Ended 31St March, 2026. 7 May - Board meets 14 May 2026 to approve audited FY26 standalone and consolidated results; trading window closes till 16 May.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/203f1893-f600-47df-83c8-8f6b102d53e2.pdf) |
| 26 Mar - Trading window closed 1 April 2026 until 48 hours after audited FY2026 results declaration. | [Closure of Trading Window 26 Mar - Trading window closed 1 April 2026 until 48 hours after audited FY2026 results declaration.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d1b81287-95f2-4546-9a9b-dc2c5c264881.pdf) |
| 24 Mar - Unsecured creditors approved demerger scheme (India Glycols → Ennature Bio Pharma, IGL Spirits) on 24 Mar 2026. | [Outcome Of Court Convened Meeting Of Unsecured Creditors Along With Voting Results And Scruitiniser Report 24 Mar - Unsecured creditors approved demerger scheme (India Glycols → Ennature Bio Pharma, IGL Spirits) on 24 Mar 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2cfec8ca-dbcc-4b01-a47f-d49c04d28488.pdf) |
| 24 Mar - 24 Mar 2026: Shareholders approved India Glycols demerger with Ennature Bio Pharma and IGL Spirits; 66.02% turnout. | [Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting 24 Mar - 24 Mar 2026: Shareholders approved India Glycols demerger with Ennature Bio Pharma and IGL Spirits; 66.02% turnout.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/26df4418-8075-4b26-961f-2902158dbd3e.pdf) |
| 21 Feb - Newspaper publication regarding notice of the Meeting of the Equity Shareholders and Unsecured Creditors as per directions of Hon''ble National Company Law Tribunal, Allahabad Bench, … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Feb - Newspaper publication regarding notice of the Meeting of the Equity Shareholders and Unsecured Creditors as per directions of Hon''ble National Company Law Tribunal, Allahabad Bench, …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9d6b1929-9b5c-49cb-8728-aeceb49cf5c7.pdf) |
| 1d - CARE placed IGL’s Rs1,229.79Cr term loan, Rs450Cr working capital, Rs850Cr BG/LC on RWD; demerger cited. | [Announcement under Regulation 30 (LODR)-Credit Rating 1d - CARE placed IGL’s Rs1,229.79Cr term loan, Rs450Cr working capital, Rs850Cr BG/LC on RWD; demerger cited.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/10957c8f-bd8c-4043-abd1-cec6e6edd51e.pdf) |
| 1d - Board meeting on 17 March 2026 to consider interim dividend; trading window closed 11–19 March 2026. | [Board Meeting Intimation for Consider Declaration Of Interim Dividend, If Any, For The Financial Year 2025-26. 1d - Board meeting on 17 March 2026 to consider interim dividend; trading window closed 11–19 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/bbbcc81f-0090-4130-bccd-90ae40e2cf8f.pdf) |
| 1d - Board meeting on 17 March 2026 to consider interim dividend; trading window closed 11–19 March 2026. | [Corporate Action-Board to consider Dividend 1d - Board meeting on 17 March 2026 to consider interim dividend; trading window closed 11–19 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4158773f-ffc1-4186-a663-92c9baa223d8.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e6ae935-c95b-4f25-9e7a-a793b2d14dce.pdf) |
| 2026-05-14 | [Outcome Of Board Meeting Held On 14Th May 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80ea0994-8620-414d-ad10-0b149c0def12.pdf) |
| 2026-02-10 | [Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended 31St December 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74431a55-d54b-40e6-8be4-3e2dd09cdc5b.pdf) |
| 2025-11-14 | [Financial Results For Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1442e507-4790-485c-81d1-a6f18e95e76f.pdf) |
| 2025-08-07 | [Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=253902fd-477b-42ef-b654-0e0576e91498.pdf) |
| 2025-02-04 | [Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Month Ended 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ad554c6-af5b-4dce-b0a8-c332cc6e6f74.pdf) |
| 2024-11-07 | [Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended On 30Th September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=084e3088-0689-4443-b713-e5be59ac2b78.pdf) |
| 2024-07-29 | [Unaudited Financial Results (Standalone And Consolidated) Of The Company For The First Quarter Ended 30Th June, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b4dd191-f953-460e-b2df-0661af4c3408.pdf) |
| 2024-05-28 | [Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended 31St March, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc817b2e-5d96-496d-bbca-7d377c52a0c6.pdf) |
| 2024-02-02 | [Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended 31St December, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74d9f2eb-778e-46b9-a362-cf3a4ea9b5f8.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c9d5844-41a1-4f6e-9b31-893a125e6567.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7af74fac-28a7-4606-9be7-11c176ebaba8.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/43cf98b1-158d-4aa9-9a57-e8d74c011449.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ee0fd2a1-60d1-4359-bc99-952a6b3e22b8.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ee0fd2a1-60d1-4359-bc99-952a6b3e22b8.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f522a026-5bc4-4d6e-92ca-ffe799e869eb.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f522a026-5bc4-4d6e-92ca-ffe799e869eb.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d532715b-c088-4be2-b619-e7a41528d1e7.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/486e665d-6467-4223-95d0-810ed0123aa7.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/47d07394-61eb-4ec4-8e04-35c30855d685.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a6b8fff3-68da-42e8-8040-74f76eefed17.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7ea40985-c46d-400b-b669-59957d7658ab.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/20671c87-1250-4d68-99c5-5b6258a07de2.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/10fe6551-cf31-4e41-b572-777163d5faa5.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2024-02-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67f6e124-c471-4a48-b41d-daa7166674df.pdf) |
| 2023-11-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a24272d0-7e94-4407-b66c-9f430263a1c5.pdf) |
| 2023-08-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=726cb9e4-ab8e-4cda-aae3-175cf0773038.pdf) |
| 2023-05-26 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95ac6dd1-6da3-446d-910d-6278f1a8db48.pdf) |
| 2023-02-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cf9d84b-7427-49a7-b7a6-832330f37158.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:59:58.224Z.